Read + Share
Amedeo Smart
Independent Medical Education
Piao H, Wu M, Qin S, Tang Z, et al. Trametinib for patients with recurrent low-grade serous ovarian cancer: A cost-effectiveness analysis. Gynecol Oncol 2022;168:17-22.PMID: 36368128
Email
LinkedIn
Facebook
Twitter
Privacy Policy